Prostate Cancer Transatlantic Consortium (CaPTC)

Keep up with the latest CaPTC activities on Twitter @CaPTC7External Web Site Policy. We are also on Facebook @CaPTC7External Web Site Policy.

About CaPTC

Because the problem of prostate cancer disparity persists, it is crucial that we begin to use new paradigms and look at the problem from fresh perspectives to develop effective solutions. The possibility for exploring new paradigms comes from studying Blacks who are connected to the U.S. via the Transatlantic Slave Trade.

CaPTC Nigeria Workshop - March 9, 2017 - Abeokuta, Nugeria

The Prostate Cancer Transatlantic Consortium (CaPTC) was formed in 2005 to address the globally disproportionate burden of prostate cancer among Black men. CaPTC is an open consortium comprising a team of prostate cancer scientists, clinicians, survivors, and advocates from North America, Europe, the Caribbean Islands, and West Africa.

CaPTC's research goals are to:

  • explore and quantify the magnitude of prostate cancer morbidity and mortality variance among Black men;
  • explore the genetic and environmental etiology of this variance, using valid and reliable instruments and biomarkers; and
  • develop ethnically sensitive, targeted approaches that will eliminate globally the prostate cancer disparities of Black men through modifiable risk factors associated with prostate cancer.

Administrative leadership of CaPTC comprises the Consortium Director, Scientific Advisory Board, and the Community Advisory Board.

Additionally, members of CaPTC have formed working groups focused on translational research, education and training, and advocacy.

Return to Top


CaPTC organizes biennial conferences on "The Science of Global Prostate Cancer Disparities in Black Men." The first conference, held in 2010, was supported by NCI's Division of Cancer Control and Population Sciences (DCCPS) and the Division of Cancer Prevention (DCP).

The next conference will be held in Barcelona, Spain, November 17-21, 2020. Registration is open and abstracts are currently being accepted for this meeting.

Science of Global Prostate Cancer Disparities Conference - November 17-21, 2020 - Barcelona, Spain

CaPTC Conference Date Location
November 17-21, 2020 Barcelona, Spain
November 7-10, 2018 Ilorin, Nigeria
November 9-12, 2016 Orlando, Florida, US
November 5-8, 2014 Montego Bay, Jamaica [PDF - 214 KB]
November 1-4, 2012 Nassau, The Bahamas [PDF]External Web Site Policy
August 27-29, 2010 Jacksonville, Florida, USExternal Web Site Policy

Global Congress on Clincial Trials in Blacks

Global Congress on Oncology Clinical Trials For Blacks Conference - November 14-16, 2018 - Lagos, Nigeria

Although the Black population is about 17% of the world population (over one billion), Blacks are disproportionately affected by cancer globally. Given the disproportionate burden of cancer in Blacks, it is important to have a significant number of Blacks participate in cancer clinical trials globally. Unfortunately, the accrual of Blacks all over the world in clinical research remains low despite ongoing attempts to improve their participation. The under-representation of Blacks in clinical trials continues to magnify the cancer health disparities experienced by this group. Overcoming the barriers for successful clinical trial enrollment of Blacks continues to be a significant challenge.

The Global Congress on Oncology Clinical Trials for BlacksExternal Web Site Policy is an international conference organized to address the global challenges of clinical trials for oncology among the Black population. The conference was held from November 14 to 16, 2018, at the Intercontinental Hotel in Lagos, Nigeria. Nigeria was selected as the conference location because it has the largest Black population in the world.

Conference  Sponsorship and Exhibition

Would your organization like to participate as sponsors and/or exhibitorsExternal Web Site Policy at these conferences? Please contact Dr. Ernest Kaninjing, Mrs. Sarah Adewumi, or Ms. Ruth Agaba at or by phone at 1-407-313-7022 or +234(0)8099427481 or +234(0)8099427482.

Return to Top


Anyone who is interested in eliminating the worldwide disproportionate burden of prostate cancer in black men can join the CaPTC.

Return to Top

Transatlantic Prostate Cancer Familial Project

The long-term goal of this CaPTC research program is to eliminate the prostate cancer disparity experienced by Black men globally. In line with this goal, this project focuses on understanding genetic, environmental and behavioral etiology of prostate cancer in West African men.

Participating CaPTC Familial Project Sites

U.S. Sites Principal Investigators
University of Florida Dr. Folakemi Odedina
Tuskegee University Dr. Clayton Yates
Sites in Nigeria – Region 1 Principal Investigators
Covenant Universtity Dr. Emeka.E.J Iweala
Lagos University Teaching Hospital Dr. Anthonia Sowumni
Lagos State University Teaching Hospital Dr. Omolara Fatriegun
Federal University of Agriculture Abeokuta Dr. Catherine Adebukola Badejo
Ace Medicare Clinics Limited, Ota Dr. O.O. Kukoyi
University of Calabar Dr. Iya Eze Bassey
Federal Medical Center, Abeokuta Dr. Chidiebere Ndukwe OGO
Sites in Nigeria – Region 2 Principal Investigators
Obafemi Awolowo University Teaching Hospitals Prof. A.A. Salako
Ahmadu Bello University Dr. Mohammed Faruk
University of Ilorin Dr. Ademola Popoola
University of Maiduguri Prof. H. A. Nggada
University of Abuja Dr. Paul Jibrin
University of Ibadan Dr. Adenike Onibokun
University of Nigeria Prof. Iheanyi Okpala
Cameroon Site Principal Investigator
University Hospital Center Yaounde Dr. Blaise Nkegoum

Return to Top

NCI Contact

  • Damali Martin, Ph.D., M.P.H., Program Director, Genomic Epidemiology Branch, Epidemiology and Genomics Research Program (EGRP), DCCPS, NCI

Return to Top